| HOME >> BIOLOGY >> TECHNOLOGY |
-- An 11% increase in EBITDA to $55.3 million versus $49.6 million in the prior-year period. Excluding charges for restructuring and integration costs, EBITDA for the period would have been $56.0 million, or $0.69 per diluted share, compared to $51.2 million and $0.59 per diluted share in the prior-year period.
Gentiva announced that it is raising its 2008 outlook for net revenues to a range of $1.32 billion to $1.35 billion, as compared to $1.28 billion to $1.32 billion, and now expects its diluted earnings per share to be between $1.36 and $1.43, up from the $1.32 to $1.40 range announced earlier this year. Projected earnings exclude special items and restructuring and integration costs.
Non-GAAP Financial Measures
The information provided in this press release includes certain non-GAAP financial measures as defined under Securities and Exchange Commission (SEC) rules. In accordance with SEC rules, the Company has provided, in the supplemental information and the footnotes to the tables, a reconciliation of those measures to the most directly comparable GAAP measures.
Conference Call and Web Cast Details
The Company will comment further on its second quarter results during
its conference call and live web cast to be held Thursday, July 31, 2008,
at 10:00 a.m. Eastern Time. To participate in the call from the United
States, Canada or an international location, dial (973) 935-2408 and
reference call #56178391. The web cast is an audio-only, one-way event. Web
cast listeners who wish to ask questions must participate in the conference
call. Log onto http://investors.gentiva.com/events.cfm to hear the web
cast. This press release is accessible at
htt
'/>"/>
| SOURCE Gentiva Health Services, Inc. Copyright©2008 PR Newswire. All rights reserved |